Thassu / Chader | Ocular Drug Delivery Systems | Buch | 978-1-032-91952-2 | www.sack.de

Buch, Englisch, 474 Seiten, Format (B × H): 156 mm x 234 mm, Gewicht: 800 g

Thassu / Chader

Ocular Drug Delivery Systems

Barriers and Application of Nanoparticulate Systems
1. Auflage 2024
ISBN: 978-1-032-91952-2
Verlag: CRC Press

Barriers and Application of Nanoparticulate Systems

Buch, Englisch, 474 Seiten, Format (B × H): 156 mm x 234 mm, Gewicht: 800 g

ISBN: 978-1-032-91952-2
Verlag: CRC Press


Drug discovery for ocular diseases has taken great strides in the last two decades. From cornea to choroid, new drugs have been formulated to address a great variety of ocular diseases. Yet without good drug delivery systems, these drugs are less effective than they might be or could even cause serious side effects. Ocular Drug Delivery Systems: Barriers and Application of Nanoparticulate Systems presents research on the development of currently marketed devices and recent trends in the topical delivery of drugs to the posterior of the eye.

With contributions from leading pharmaceutical researchers and industry experts, eye researchers, surgeons, pharmacologists from academia, the National Eye Institute, and leading ophthalmic companies such as Pfizer, Allergan, and Novartis, the book presents the state of the art in the use of nanoparticles in ocular drug delivery systems and also sets the stage for future developments.

This volume provides both a current evaluation and a future roadmap for developments in ocular drug delivery. The subjects range from biological needs to material challenges and finally to clinical applications for improving drug delivery for conditions where treatments already exist. It also explores areas where effective drugs may be currently available but yet need a safe, efficient, and efficacious delivery vehicle.

Thassu / Chader Ocular Drug Delivery Systems jetzt bestellen!

Zielgruppe


Academic

Weitere Infos & Material


Basic Considerations. Ocular Barriers. Ocular Compartment Drug Delivery. Drug Delivery Systems. Technology and Materials Development.


Deepak Thassu is the Vice President of Pharmaceutical Development at Pharmanova, Inc., in Victor, New York.

Gerald Chader is Chief Scientific Officer of the Doheny Retina Institute at USC Medical School in Los Angeles.



Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.